Diadenosine polyphosphate-induced activation of purinoceptor subtypes increases levels of intracellular Ca2+ in human fetal astrocytes

B. A. Dolhun, C. P. Holden, J. D. Geiger

Research output: Contribution to journalArticle

Abstract

Diadenosine polyphosphates (ApnAs) are released from and act on P2-subtype purinoceptors in neural cells. Using single cell fura-2 fluorescence to measure levels of free cytosolic Ca2+ ([Ca2+]j) we determined the extent to which ApnAs activate purinoceptors and increase [Ca2+]j in human fetal cultured astrocytes. Diadenosine triphosphate, diadenosine tetraphosphate and diadenosine pentaphosphate significantly increased [Ca2+]j. Diadenosine pentaphosphate (Ap5A) pressure injected (100 μM) onto astrocytes increased [Ca2+]; in 39 out of 65 astrocytes tested; peak increases ranged from 500 to 2000 nM (mean ±SEM, 820 ±142 nM). Chelation of extracellular Ca2+ with 2 mM EGTA completely blocked ApnA-induced increases in [Ca2+];. Pyridoxal-phosphate-6-azophenel-2',4'disulphonic acid tetrasodium (PPADS, 300 μM), a nonselective P2X/P2Y purinoceptor antagonist blocked, by over 50 %, Ap5A-induced increases in [Ca2+]j. Thapsigargin (4 μM), a Ca2+ ATPase inhibitor that depletes Ca2+ stores, blocked, by over 75%, ApsA-induced increases in [Ca2+]j. Activation of purinoceptor subtypes by ApnAs results in significant increases in [Ca2+]j and a significant component of the [Ca2+]; is released from intracellular stores in human fetal astrocytes.

Original languageEnglish (US)
Pages (from-to)A413
JournalFASEB Journal
Volume10
Issue number3
StatePublished - Dec 1 1996

Fingerprint

Purinergic Receptors
Polyphosphates
polyphosphates
astrocytes
Astrocytes
Chemical activation
calcium
Purinergic P2X Receptor Antagonists
Purinergic P2Y Receptor Antagonists
Purinergic P2 Receptors
Pyridoxal Phosphate
Thapsigargin
Calcium-Transporting ATPases
Fura-2
Egtazic Acid
Chelation
Fluorescence
Pressure
Scanning electron microscopy
Acids

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Diadenosine polyphosphate-induced activation of purinoceptor subtypes increases levels of intracellular Ca2+ in human fetal astrocytes. / Dolhun, B. A.; Holden, C. P.; Geiger, J. D.

In: FASEB Journal, Vol. 10, No. 3, 01.12.1996, p. A413.

Research output: Contribution to journalArticle

@article{7a48a8483eff483a92bf6b791811c2d0,
title = "Diadenosine polyphosphate-induced activation of purinoceptor subtypes increases levels of intracellular Ca2+ in human fetal astrocytes",
abstract = "Diadenosine polyphosphates (ApnAs) are released from and act on P2-subtype purinoceptors in neural cells. Using single cell fura-2 fluorescence to measure levels of free cytosolic Ca2+ ([Ca2+]j) we determined the extent to which ApnAs activate purinoceptors and increase [Ca2+]j in human fetal cultured astrocytes. Diadenosine triphosphate, diadenosine tetraphosphate and diadenosine pentaphosphate significantly increased [Ca2+]j. Diadenosine pentaphosphate (Ap5A) pressure injected (100 μM) onto astrocytes increased [Ca2+]; in 39 out of 65 astrocytes tested; peak increases ranged from 500 to 2000 nM (mean ±SEM, 820 ±142 nM). Chelation of extracellular Ca2+ with 2 mM EGTA completely blocked ApnA-induced increases in [Ca2+];. Pyridoxal-phosphate-6-azophenel-2',4'disulphonic acid tetrasodium (PPADS, 300 μM), a nonselective P2X/P2Y purinoceptor antagonist blocked, by over 50 {\%}, Ap5A-induced increases in [Ca2+]j. Thapsigargin (4 μM), a Ca2+ ATPase inhibitor that depletes Ca2+ stores, blocked, by over 75{\%}, ApsA-induced increases in [Ca2+]j. Activation of purinoceptor subtypes by ApnAs results in significant increases in [Ca2+]j and a significant component of the [Ca2+]; is released from intracellular stores in human fetal astrocytes.",
author = "Dolhun, {B. A.} and Holden, {C. P.} and Geiger, {J. D.}",
year = "1996",
month = "12",
day = "1",
language = "English (US)",
volume = "10",
pages = "A413",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Diadenosine polyphosphate-induced activation of purinoceptor subtypes increases levels of intracellular Ca2+ in human fetal astrocytes

AU - Dolhun, B. A.

AU - Holden, C. P.

AU - Geiger, J. D.

PY - 1996/12/1

Y1 - 1996/12/1

N2 - Diadenosine polyphosphates (ApnAs) are released from and act on P2-subtype purinoceptors in neural cells. Using single cell fura-2 fluorescence to measure levels of free cytosolic Ca2+ ([Ca2+]j) we determined the extent to which ApnAs activate purinoceptors and increase [Ca2+]j in human fetal cultured astrocytes. Diadenosine triphosphate, diadenosine tetraphosphate and diadenosine pentaphosphate significantly increased [Ca2+]j. Diadenosine pentaphosphate (Ap5A) pressure injected (100 μM) onto astrocytes increased [Ca2+]; in 39 out of 65 astrocytes tested; peak increases ranged from 500 to 2000 nM (mean ±SEM, 820 ±142 nM). Chelation of extracellular Ca2+ with 2 mM EGTA completely blocked ApnA-induced increases in [Ca2+];. Pyridoxal-phosphate-6-azophenel-2',4'disulphonic acid tetrasodium (PPADS, 300 μM), a nonselective P2X/P2Y purinoceptor antagonist blocked, by over 50 %, Ap5A-induced increases in [Ca2+]j. Thapsigargin (4 μM), a Ca2+ ATPase inhibitor that depletes Ca2+ stores, blocked, by over 75%, ApsA-induced increases in [Ca2+]j. Activation of purinoceptor subtypes by ApnAs results in significant increases in [Ca2+]j and a significant component of the [Ca2+]; is released from intracellular stores in human fetal astrocytes.

AB - Diadenosine polyphosphates (ApnAs) are released from and act on P2-subtype purinoceptors in neural cells. Using single cell fura-2 fluorescence to measure levels of free cytosolic Ca2+ ([Ca2+]j) we determined the extent to which ApnAs activate purinoceptors and increase [Ca2+]j in human fetal cultured astrocytes. Diadenosine triphosphate, diadenosine tetraphosphate and diadenosine pentaphosphate significantly increased [Ca2+]j. Diadenosine pentaphosphate (Ap5A) pressure injected (100 μM) onto astrocytes increased [Ca2+]; in 39 out of 65 astrocytes tested; peak increases ranged from 500 to 2000 nM (mean ±SEM, 820 ±142 nM). Chelation of extracellular Ca2+ with 2 mM EGTA completely blocked ApnA-induced increases in [Ca2+];. Pyridoxal-phosphate-6-azophenel-2',4'disulphonic acid tetrasodium (PPADS, 300 μM), a nonselective P2X/P2Y purinoceptor antagonist blocked, by over 50 %, Ap5A-induced increases in [Ca2+]j. Thapsigargin (4 μM), a Ca2+ ATPase inhibitor that depletes Ca2+ stores, blocked, by over 75%, ApsA-induced increases in [Ca2+]j. Activation of purinoceptor subtypes by ApnAs results in significant increases in [Ca2+]j and a significant component of the [Ca2+]; is released from intracellular stores in human fetal astrocytes.

UR - http://www.scopus.com/inward/record.url?scp=33749137973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749137973&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749137973

VL - 10

SP - A413

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -